Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 81-90 of 118

Page
per page
  1. TG 100801
    A3870 TG 100801
    Target: VEGFR|FGFR|Src|Fyn kinase
    Summary: Multi-kinase inhibitor
      Soluble in DMSO
  2. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  3. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  4. NT157
    B7808 NT157
     1 Citation
    Summary: IRS-1/2 inhibitor, inhibits IGF-1R and STAT3 signaling pathway
  5. WZ4002
    A1389 WZ4002
    Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent
      ≥24.7 mg/mL
  6. Varlitinib (ARRY334543)
    A8365 Varlitinib (ARRY334543)
    Summary: ErbB inhibitor
      ≥23.35 mg/mL
  7. GS-9973
    B3553 GS-9973
    Target: Syk
    Summary: Syk inhibitor, orally bioavailable and selective
      insoluble in EtOH; insoluble in H2O; ≥20.55 mg/mL
  8. SR3335
    A3836 SR3335
    Summary: RORα agonist,partial inverse and selective
  9. Staurosporine
    A8192 Staurosporine
     6 Citation
    Summary: Protein kinase inhibitor,potent and cell permeable
      insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL
  10. Toceranib
    A3879 Toceranib
    Summary: c-Kit/VEGFR/PDGFR inhibtor
      soluble in DMSO

Items 81-90 of 118

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 4item
  2. Ack1 1 item
  3. Axl 1 item
  4. ALK 4item
  5. Broad Spectrum Protein Kinase Inhibitor 3item
  6. c-FMS 1 item
  7. c-Kit 2item
  8. c-MET 8item
  9. c-RET 3item
  10. CSF-1R 1 item
  11. EGFR 24item
  12. FAK 4item
  13. FGFR 6item
  14. FLT3 4item
  15. HER2 7item
  16. IGF1R 2item
  17. Insulin Receptor 3item
  18. IRAK 1 item
  19. Lck 1 item
  20. LRRK2 4item
  21. PDGFR 9item
  22. PTKs/RTKs 1 item
  23. Pyk2 2item
  24. ROR 1 item
  25. Spleen Tyrosine Kinase (Syk) 2item
  26. Src 5item
  27. Tie-2 2item
  28. Trk 1 item
  29. VEGFR 30item
Specificity
  1. Selective 46item
Reversibility
  1. Reversible 6item
  2. Irreversible 4item
Target
  1. Raf 4item
  2. CSF-1R 1 item
  3. FLT3 4item
  4. Eph Receptors 1 item
  5. VEGFR 24item
  6. PDGFR 7item
  7. c-Kit 5item
  8. RET 2item
  9. Bcr-Abl 2item
  10. FGFR 7item
  11. MET 4item
  12. Src 2item
  13. Trk Receptors 2item
  14. EGFR 11item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. PKC 1 item
  21. Pyk2 3item
  22. LRRK2 4item
  23. Insulin and Insulin-like Receptors 1 item
  24. ALK 1 item
  25. PKG 1 item
  26. PKA 1 item
  27. Myosin light chain kinases (MLCKs) 1 item
  28. Tie-2 3item
  29. Flk-1 1 item
  30. KDR 1 item
  31. Fyn kinase 1 item
  32. c-Fms tyrosine kinase 1 item
  33. Lyn kinase 1 item
  34. ErbB-2 1 item
  35. DCLK2 1 item
  36. Flk1 1 item
Reported Experiments
  1. Animal Experiments 58item
  2. Cell Experiments 42item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 44item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 2item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item